Search results for: 'ion selective electron market 2014'
- Related search terms
- electronic+test+and+measurement+market
- market analysis of rf energy harvesting technolog
- market analysi of rf energy harvesting technolog
- market+size+of+china's+overseas+marketing+industry
- market 08 00 00 00
-
21 Aug 2020  |  Global  |  Market Research
Hybridization of Clinical Trial Designs Reviving Global CRO Market Post-pandemic, 2019–2024
Patient-centric and Safety-focused Logistical Solutions will Create New Growth Opportunities
In this research deliverable, Frost & Sullivan’s analyst team offers a bold perspective on the post-pandemic growth opportunities for the global CRO market. With the increased threat of COVID-19 and world-wide lockdowns in effect, the contract research organization (CROs) market is seeing interruptions in ongoing clinical trials and delays of new t...
$4,950.00
Special Price $3,712.50 save 25 %
-
27 Aug 2020  |  Global  |  Market Research
Smart Labs as Key Drivers for the Digital Transformation of Diagnostic Laboratories, 2020
Robotic Automation, Internet of Things (IoT), and Artificial Intelligence (AI) Offering Growth Opportunities for Academic and Commercial Diagnostics Labs
Diagnostic academic and commercial research labs suffer from cost pressures, given the ongoing Protecting Access to Medicare Act (PAMA) regulations and reproducibility issues, and are under productivity strain. The recent COVID-19 pandemic leading to increasing test volumes and renewed focus on research and development (R&D) to drive innovation wil...
$3,000.00
Special Price $2,250.00 save 25 %
-
23 Oct 2020  |  North America  |  Market Research
Access to New Therapy Areas to Drive Major Growth in the Global Biosimilars Market, 2020–2026
Outsourced Manufacturing of the Complex Third Wave of Biosimilars to Spark New Growth Opportunities
In this research service, the Transformational Health team at Frost & Sullivan provides critical insights into the global biosimilar industry, highlighting the key growth opportunities, market revenue forecasts, and trends that will influence the industry with the emergence of the third wave of biosimilars. The global third-wave biosimilars market ...
$4,950.00
Special Price $3,712.50 save 25 %
-
30 Apr 2021  |  North America  |  Tracker
US COVID-19 Vaccines and Therapeutics Tracker—Market Insights and Trends, H1 2021
Agnostic Vaccine Platform Technology Enhancing Future Growth Potential of Participants in the Value Chain
This study by Frost & Sullivans Healthcare and Life Sciences team provides critical insights into the US COVID-19 vaccines and therapeutics market, including developing vaccines, supply chain considerations, and requirements to manage distribution. The study also identifies actionable and profitable growth opportunities for industry participants. T...
$2,450.00
Special Price $1,837.50 save 25 %
-
12 Aug 2020  |  North America  |  Market Research
New Drug Development for Rare Pediatric Disorders Sustaining High Growth in the Global Orphan Drugs Market, 2019–2025
AI-powered Early Disease Diagnosis and Drug Repurposing will Create New Growth Opportunities
Rare diseases have been an increasing area of focus as three waves have converged in recent years: genomic research and innovations becoming mainstream; the forthcoming regulatory policies and financial incentives put in place by the federal agencies; and the increasingly patient-centric and coordinated efforts of patient advocacy groups, caregive...
$4,950.00
Special Price $3,712.50 save 25 %
-
23 Oct 2020  |  Global  |  Market Research
Supply Chain Optimization and Decentralized Manufacturing to Expand the Contract Cell and Gene Therapy Manufacturing Market, 2020–2026
Automation Deployed to Contain Cost of Goods Sold and Vector Manufacturing Standardization will Create New Growth Opportunities
The cell and gene therapy segment is one of the fastest growing segments in the biopharmaceutical space. While the science behind the therapy has grown by leaps and bounds on the back of decades worth of research, manufacturing has unfortunately lagged behind. To fully harness the curative potential of these therapies and ensure greater reach and a...
$4,950.00
Special Price $3,712.50 save 25 %
-
26 Sep 2019  |  Global  |  Market Research
Growth Insight—Role of AI in the Pharmaceutical Industry, Global, 2018–2022
Exploring Key Investment Trends, Companies-to-Action, and Growth Opportunities for AI in the Pharmaceutical Industry
Pharmaceutical drug discovery and development processes suffer from declining success rates and a stagnant pipeline. Artificial Intelligence (AI) supported by Big Data could be a key element that can provide an effectual solution. There has been a rapid growth in the data generated within the life sciences and pharmaceutical industries. This stems ...
$4,950.00
Special Price $3,712.50 save 25 %
-
17 Jun 2021  |  North America  |  Market Research
Global Biologics Contract Development and Manufacturing Organizations Growth Opportunities
Asset Co-Development with Clinical-stage Biopharmaceutical Companies and Disruptive Technologies Present Future Growth Potential
This study presents Frost & Sullivans overall market and segment-wise revenue forecasts of the global biologics contract development and manufacturing organizations (bio-CDMO) market. It also highlights key growth opportunities for bio-CDMO market participants based on the main evolution in their business models and strategic approaches, as well as...
$4,950.00
Special Price $3,712.50 save 25 %
-
10 Jan 2020  |  Asia Pacific  |  Market Research
Growth Insights on China’s Pharmaceutical Industry, Forecast to 2025
Expedited Regulatory Reviews, Accompanied by Surging Novel Drug Pipelines and a Realigned Distribution System will Propel the Chinese Pharma Industry
With over-4000 pharmaceutical players, China is the second largest pharmaceutical industry globally. Although highly fragmented, global pharma and biopharmaceutical players such as Novartis, Novo Nordisk, and AstraZeneca, have a significant hold capturing at least 8-10Percentage of the market. The market being highly dependent on its distributor ne...
$10,000.00
Special Price $7,500.00 save 25 %
-
23 Aug 2019  |  South Asia, Middle East & North Africa  |  Market Outlook
Middle East and North Africa (MENA) Life Sciences Industry Outlook, Forecast to 2020
Increased Local Manufacturing and Government Spending on Lifestyle Diseases to be Key Driving Factors in 2020
In this research deliverable, Frost & Sullivan’s analyst team provides bold perspectives and predictions for the Middle East and North Africa (MENA) region’s life sciences industry in 2020. The markets covered include pharmaceuticals, biotechnology, and in-vitro diagnostics. The analysis captures the impact of trends that are expected to transpire ...
$4,950.00
Special Price $3,712.50 save 25 %